Gregory Schiffman

Gregory T.
Schiffman is Director at Nanomix, Inc. since 2005.
Independent Director at BioEclipse Therapeutics, Inc. since 2016.
Independent Director at Fabric.
AI, Inc. since 2020.
Director at Mirror Biologics Inc. Former Director at VNUS Medical Technologies, Inc. from 2006 to 2009.
Director at Xenogen Corp.
from 2005 to 2006.
Director at IMPAC Medical Systems, Inc. from 2003 to 2005.
Non-Executive Director at Entelos, Inc. Independent Director at DropCar Operating Co., Inc. from 2018 to 2020.
Director at Nanomix Corp.
Vice President & Controller at Applied Biosystems, Inc. from 1998 to 2001.
CFO, EVP-Finance & Head-Investor Relations at StemCells, Inc. from 2014 to 2016.
Manufacturing Manager at HP, Inc. Principal at International Business Machines Corp.
Chief Financial Officer & Executive Vice President at Affymetrix, Inc. from 2001 to 2006.
Executive Vice President at Dendreon Corp.
in 2013.
Controller-PC Manufacturing Operations at Hewlett-Packard France SAS. Chief Financial Officer at Iovance Biotherapeutics, Inc. from 2016 to 2017.
Chief Financial Officer at Absci Corp.
from 2020 to 2023.
Chief Financial Officer at Vineti, Inc. from 2017 to 2018.
Education includes an undergraduate degree from DePaul University in 1985 and an MBA from Kellogg School of Management in 1987.